Prostate-specific Membrane Antigen PET in Prostate Cancer

被引:48
|
作者
Lawhn-Heath, Courtney [1 ]
Salavati, Ali [3 ]
Behr, Spencer C. [1 ,2 ]
Rowe, Steven P. [3 ]
Calais, Jeremie [4 ]
Fendler, Wolfgang P. [5 ,6 ]
Eiber, Mattias [7 ]
Emmett, Louise [8 ]
Hofman, Michael S. [9 ,10 ]
Hope, Thomas A. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 505 Parnassus Ave,M391, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, 505 Parnassus Ave,M391, San Francisco, CA 94143 USA
[3] Johns Hopkins Univ, Dept Radiol & Radiol Sci, Baltimore, MD USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson Translat Theranost Div, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[5] Univ Duisburg Essen, Dept Nudear Med, Essen, Germany
[6] Univ Hosp Essen, German Canc Consortium DKTK, Essen, Germany
[7] Tech Univ Munich, Dept Nucl Med, Munich, Germany
[8] St Vincents Hosp, Dept Theranost & Nucl Med, Sydney, NSW, Australia
[9] Peter MacCallum Canc Ctr, Prostate Theranost & Imaging Ctr Excellence ProsT, Melbourne, Vic, Australia
[10] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
关键词
I-AND-T; BIOCHEMICAL RECURRENCE; RADIATION-DOSIMETRY; RADICAL PROSTATECTOMY; GA-68-PSMA-11; PET/CT; BIODISTRIBUTION; RADIOTHERAPY; THERAPY; MEN; RECOMMENDATIONS;
D O I
10.1148/radiol.2021202771
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceuticals are playing a large role at the time of initial staging and biochemical recurrence for localizing prostate cancer, as well as in other emerging clinical settings. PSMA PET has demonstrated increased detection rate compared with conventional imaging and has been shown to change management plans in a substantial percentage of cases. The aims of this narrative review are to highlight the development and clinical impact of PSMA PET-radiopharmaceuticals, to compare PSMA to other agents such as fluorine 18 fluciclovine and carbon 11 choline, and to highlight some of the individual PSMA PET agents that have contributed to the advancement of prostate cancer imaging. (C) RSNA, 2021
引用
收藏
页码:248 / 260
页数:13
相关论文
共 50 条
  • [1] Re: Prostate-Specific Membrane Antigen PET in Prostate Cancer
    Siegel, Cary
    [J]. JOURNAL OF UROLOGY, 2021, 206 (04): : 1044 - 1044
  • [2] Advances in prostate-specific membrane antigen PET of prostate cancer
    Bouchelouche, Kirsten
    Choyke, Peter L.
    [J]. CURRENT OPINION IN ONCOLOGY, 2018, 30 (03) : 189 - 196
  • [3] PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen
    Mease, Ronnie C.
    Foss, Catherine A.
    Pomper, Martin G.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (08) : 951 - 962
  • [4] Targeted PET imaging for prostate-specific membrane antigen in prostate cancer
    Hope, Thomas A.
    Aggarwal, Rahul R.
    Westphalen, Antonio C.
    Cooperberg, Matthew R.
    Greene, Kirsten L.
    [J]. FUTURE ONCOLOGY, 2016, 12 (21) : 2393 - 2396
  • [5] Prostate-specific Membrane Antigen PET: Standard Imaging in Prostate Cancer COMMENT
    Jadvar, Hossein
    [J]. RADIOLOGY, 2022, 304 (03) : 609 - 610
  • [6] Prostate-specific membrane antigen PET/computed tomography for staging prostate cancer
    Ravi Kumar, Aravind S.
    Lawrentschuk, Nathan
    Hofman, Michael S.
    [J]. CURRENT OPINION IN UROLOGY, 2020, 30 (05) : 628 - 634
  • [7] Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and Challenges
    Oh, So Won
    Cheon, Gi Jeong
    [J]. KOREAN JOURNAL OF RADIOLOGY, 2018, 19 (05) : 819 - 831
  • [8] Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrence
    Ferdinandus, Justin
    Fendler, Wolfgang Peter
    Hadaschik, Boris
    Herrmann, Ken
    [J]. CURRENT OPINION IN UROLOGY, 2020, 30 (05) : 635 - 640
  • [9] Prostate-Specific Membrane Antigen-Negative MetastasesA Potential Pitfall in Prostate-Specific Membrane Antigen PET
    Noto, Benjamin
    Springe, Katharina Auf Der
    Huss, Sebastian
    Allkemper, Thomas
    Stegger, Lars
    [J]. CLINICAL NUCLEAR MEDICINE, 2018, 43 (06) : E186 - E188
  • [10] Prostate-specific Membrane Antigen PET: Therapy Response Assessment in Metastatic Prostate Cancer
    Barbosa, Felipe G.
    Queiroz, Marcelo A.
    Ferraro, Daniela A.
    Nunes, Rafael F.
    Dreyer, Priscilla R.
    Zaniboni, Elaine C.
    Costa, Larissa B.
    Bastos, Diogo A.
    Marin, Jose Flavio G.
    Buchpiguel, Carlos A.
    [J]. RADIOGRAPHICS, 2020, 40 (05) : 1412 - 1430